Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

ASAHI KASEI CORP (3407)
Mes dernières consult.
Most popular
Report
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Asahi Kasei to buy Zoll Med for up to $1.2 billion -Nikkei

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/12/2012 | 08:22am CET

Japan's Asahi Kasei Corp will launch a tender offer bid to acquire Zoll Medical Corp, a medical equipment firm, for up to 100 billion yen ($1.2 billion), the Nikkei business daily reported on Monday.

The maker of chemicals and construction materials will be holding a press conference at 3.30 a.m. EDT, which will be attended by Taketsugu Fujiwara, the president of Asahi Kasei Corp, .

($1 = 82.3550 Japanese yen)

(Reporting by Chris Gallagher; Editing by Joseph Radford)

Stocks treated in this article : Asahi Kasei Corp., ZOLL Medical Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
01/16 ASAHI KASEI : Home Order Trends – December 2017
01/11 ASAHI KASEI : Capacity expansions for LIB separator
01/04 ASAHI KASEI : Patent Issued for Power Supply Circuit (USPTO 9853540)
01/04 ASAHI KASEI : "Porous Hollow Fiber Membrane" in Patent Application Approval Proc..
2017 ASAHI KASEI : Construction of new spinning plant for Planova™ filters
2017 ASAHI KASEI : U.S. Patents Awarded to Inventors in Vermont (Dec. 9)
2017 ASAHI KASEI : Federal Contracts Awarded to Companies in Massachusetts (Dec. 9)
2017 ASAHI KASEI : MILITARY $400 Million Federal Contract Awarded to Zoll Medical
2017 ASAHI KASEI : ZOLL and Myant enter strategic R&D collaboration
2017 ASAHI KASEI : Sanofi and Asahi Kasei Pharma enter license agreement for marketin..
More news
News from SeekingAlpha
2017 Asahi Kasei Corp. ADR 2017 Q2 - Results - Earnings Call Slides
2017 Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
Financials ( JPY)
Sales 2018 2 019 B
EBIT 2018 -
Net income 2018 145 B
Debt 2018 177 B
Yield 2018 1,79%
P/E ratio 2018 14,91
P/E ratio 2019 14,87
EV / Sales 2018 1,12x
EV / Sales 2019 1,05x
Capitalization 2 088 B
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 1 445  JPY
Spread / Average Target -2,9%
EPS Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Shuichi Sakamoto Director & Head-Corporate Finance
Hideyuki Yamagishi Senior Executive Officer, General Manager-R&D
Norio Ichino Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP0.74%18 838
AIR LIQUIDE3.19%56 842
SHIN-ETSU CHEMICAL CO LTD2.48%47 839
PRAXAIR6.12%46 410
LYONDELLBASELL INDUSTRIES6.67%45 714
NAN YA PLASTICS CORP--.--%21 855